News by date
- ► 2014
- ► 2011
- ► September
GalChimia signs deal with HQL Pharmaceuticals
Monday, 19 September 2011 00:00 Written by Manufacturing Chemist
GalChimia, a Spanish provider of synthetic organic chemistry services is to work with HQL Pharmaceuticals for cancer research.
The Santiago de Compostela-based firm said it would work with the Israeli drug discovery firm to develop small molecules that cause programmed cell death by inhibiting protein-protein interactions targeting apoptotic pathways, which is said to play a key role in oncology.
read the whole news at Manufacturing Chemist